BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34499916)

  • 1. Evidence for ceramide induced cytotoxicity in retinal ganglion cells.
    Fan J; Liu J; Liu J; Chen C; Koutalos Y; Crosson CE
    Exp Eye Res; 2021 Oct; 211():108762. PubMed ID: 34499916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
    Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
    Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury.
    Fan J; Wu BX; Crosson CE
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4476-84. PubMed ID: 27571014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.
    Abdul Y; Akhter N; Husain S
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.
    Husain S; Abdul Y; Crosson CE
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4289-98. PubMed ID: 22661469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of P2X
    Zhang Y; Xu Y; Sun Q; Xue S; Guan H; Ji M
    Exp Eye Res; 2019 Nov; 188():107771. PubMed ID: 31445901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension.
    Alsarraf O; Fan J; Dahrouj M; Chou CJ; Yates PW; Crosson CE
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7486-93. PubMed ID: 25358731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.
    Syc-Mazurek SB; Fernandes KA; Libby RT
    Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha mediates activation of NF-κB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways.
    Dvoriantchikova G; Ivanov D
    Eur J Neurosci; 2014 Oct; 40(8):3171-8. PubMed ID: 25160799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
    Zhu Y; Zhang L; Gidday JM
    Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection.
    Husain S; Ahmad A; Singh S; Peterseim C; Abdul Y; Nutaitis MJ
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6489-6499. PubMed ID: 29288267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location.
    Feng L; Zhao Y; Yoshida M; Chen H; Yang JF; Kim TS; Cang J; Troy JB; Liu X
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1106-17. PubMed ID: 23322576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
    Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
    Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling.
    Omodaka K; Nishiguchi KM; Yasuda M; Tanaka Y; Sato K; Nakamura O; Maruyama K; Nakazawa T
    Brain Res; 2014 Oct; 1586():203-12. PubMed ID: 25160129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin mediates mTOR signaling in reactive astrocytes and reduces retinal ganglion cell loss.
    Li N; Wang F; Zhang Q; Jin M; Lu Y; Chen S; Guo C; Zhang X
    Exp Eye Res; 2018 Nov; 176():10-19. PubMed ID: 29928901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.
    Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J
    Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death.
    Bai Y; Shi Z; Zhuo Y; Liu J; Malakhov A; Ko E; Burgess K; Schaefer H; Esteban PF; Tessarollo L; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6639-51. PubMed ID: 20574020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma.
    Gallego BI; Salazar JJ; de Hoz R; Rojas B; Ramírez AI; Salinas-Navarro M; Ortín-Martínez A; Valiente-Soriano FJ; Avilés-Trigueros M; Villegas-Perez MP; Vidal-Sanz M; Triviño A; Ramírez JM
    J Neuroinflammation; 2012 May; 9():92. PubMed ID: 22583833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells.
    Fuchs C; Forster V; Balse E; Sahel JA; Picaud S; Tessier LH
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2983-91. PubMed ID: 16043875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.